You are here

24-05-2019 | ©iStockphoto CIPhotos
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone diseases, enabling novel therapies for hundreds of millions of people worldwide suffering from bone cancer, bacterial bone infections and osteoporosis.
26-11-2018 | © picture
Key nutrients can improve vision both in ageing and in healthy eyes, according to EU-funded research. Doctors are now prescribing supplements of these nutrients, while the researchers are investigating other possible health benefits.
20-03-2018 | Our Mythical Childhood, 2013, mixed media on cardboard © Matylda Tracewska
How does the past inform the lives of children and young people? A global team of EU-funded researchers is examining this issue by assessing how stories from classical antiquity impact on popular culture and society. The project’s results and outputs will provide valuable resources for scholars and teachers.
17-01-2017 | © Portrait: Kevin Homewood | © Illustration: Ion Beam Centre, University of Surrey, Guildford, Surrey, GU2 5XH, UK
In an early application of a new discovery in semiconductor physics, EU-funded researchers have developed a silicon infrared detector that is simpler and cheaper than conventional detectors. The ultimate goal is a silicon-based laser.
22-07-2016 | © Ivilin Stoianov, Marco Zorzi
European researchers have designed brain-like artificial neural networks capable of numerical and spatial cognition and written language processing without any explicit training or pre-programming. Their work, based on the machine-learning approach of generative models, significantly advances the development of self-learning artificial intelligence, while also deepening understanding of human cognition.
25-02-2016 | © picture
An ERC-funded project is conducting groundbreaking research into a rare form of leukaemia, proving the effectiveness in patients of non-chemotherapy-based treatments that target the genetic cause of the disease. The Hairy Cell Leukemia project, launched by the Institute of Hematology at the University of Perugia in Italy with funding from the European Research Council, is one of the world’s foremost initiatives to develop a targeted therapy for hairy cell leukaemia (HCL), a rare form of blood cancer.